APYXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Apyx Medical Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$2.42−0.13 (-5.10%)
Close on Oct 19, 2026
- Market cap
- $106.12M
- P/E (TTM)
- –
- Dividend yield
- –
Apyx Medical Corp revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Surgical Aesthetics [Member] | $45.33M | $38.61M | – | – | – | – | – | – | – | – | 85.8% | +17.4% |
| OEM [Member] | $7.51M | $9.50M | $8.97M | – | – | – | – | – | – | – | 14.2% | -20.9% |
| Core | – | – | – | – | – | – | – | – | $28.65M | $27.81M | – | – |
| OEM | – | – | $8.97M | $7.71M | $5.53M | $5.50M | $5.56M | $3.62M | $2.60M | $5.33M | – | – |
| Advanced Energy [Member] | – | $38.61M | $43.38M | $36.80M | $42.99M | $22.21M | $22.68M | $12.99M | $7.64M | $3.49M | – | – |
| J-Plasma [Member] | – | – | – | – | – | – | – | – | – | $3.49M | – | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Surgical Aesthetics [Member] | $6.69M | -$3.89M | – | – | – | – | – | – | – | – | -271.9% |
| OEM [Member] | $1.86M | $1.97M | $2.52M | – | – | – | – | – | – | – | -6.0% |
| Core | – | – | – | – | – | – | – | – | $8.62M | $7.60M | – |
| OEM | – | – | $2.52M | $1.64M | $1.03M | $1.84M | $2.14M | $1.80M | $1.35M | $3.05M | – |
| Advanced Energy [Member] | – | -$3.89M | -$956.00K | -$4.10M | $2.78M | -$7.13M | -$8.05M | -$6.33M | -$3.96M | -$4.81M | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cauteries | – | – | – | – | – | – | – | – | $7.14M | $7.10M | – | – |
| Electrosurgical | – | – | – | – | – | – | – | – | $25.73M | $20.90M | – | – |
| Other | – | – | – | – | – | – | – | – | $3.58M | $5.92M | – | – |
| Lighting | – | – | – | – | – | – | – | – | $2.44M | $2.71M | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $38.80M | $34.02M | $38.35M | $31.21M | $32.98M | $18.81M | $19.58M | $12.86M | $8.89M | $8.48M | 73.4% | +14.0% |
| Non-US [Member] | $14.04M | $14.08M | $14.00M | $13.30M | $15.54M | $8.90M | $8.65M | $3.75M | $1.35M | $344 | 26.6% | -0.3% |
| International | – | – | – | – | – | – | – | – | – | $4.58M | – | – |
From the segment and revenue-disaggregation notes of Apyx Medical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.